Literature DB >> 3861237

Characterization of a differentiation-inhibitory activity from nondifferentiating mouse myeloid leukemia cells.

J Okabe-Kado, M Hayashi, Y Honma, M Hozumi.   

Abstract

Mouse myeloid leukemic M1 cells are induced to differentiate by various differentiation inducers. Activity for inhibition of induction of differentiation of M1 cells (I-activity) has been found in conditioned medium of variant M1 cell clones resistant to differentiation inducers, and this I-activity has been shown to be closely associated with resistance of the cells to differentiation inducers. In this work, the I-activity in the conditioned medium of the resistant M1 cells was shown to bind to Carboxymethyl-Sepharose CL-6B and to be eluted with 0.27-0.4 M NaCl. The profile of gel filtration of I-activity from Sephadex G-200 indicated considerable heterogeneity in molecules with I-activity; the apparent molecular range of the main I-activity was 60,000-80,000. On chromatofocusing, the I-activity was eluted with Polybuffer 96-acetic acid at pH 8.8-9.0. The I-activity was inactivated by treatment with trypsin or by heating at 75 degrees C for 30 min. Therefore, the main I-activity seemed to be due to a basic protein(s).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861237

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

Review 1.  Physiological and pathological relevance of extracellular NM23/NDP kinases.

Authors:  Junko Okabe-Kado; Takashi Kasukabe
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

2.  Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.

Authors:  Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma; Hirofumi Kobayashi; Nobuo Maseki; Yasuhiko Kaneko
Journal:  Int J Hematol       Date:  2009-08-05       Impact factor: 2.490

3.  Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies.

Authors:  Junko Okabe-Kado; Takashi Kasukabe; Yasuhiko Kaneko
Journal:  Adv Hematol       Date:  2011-09-19

4.  Induction of differentiation of mouse myeloid leukemia M1 cells by serum of patients with chronic myeloid leukemia.

Authors:  J Okabe-Kado; Y Honma; M Hayashi; M Hozumi; K Sampi; M Sakurai; K Hino; N Tsuruoka
Journal:  Jpn J Cancer Res       Date:  1988-12

5.  Inhibitory action of transforming growth factor-beta on induction of differentiation of myeloid leukemia cells.

Authors:  J Okabe-Kado; Y Honma; M Hayashi; M Hozumi
Journal:  Jpn J Cancer Res       Date:  1989-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.